Thomas Cerny

1.4k total citations
28 papers, 966 citations indexed

About

Thomas Cerny is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Thomas Cerny has authored 28 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 10 papers in Surgery. Recurrent topics in Thomas Cerny's work include Cancer Genomics and Diagnostics (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Gastrointestinal disorders and treatments (3 papers). Thomas Cerny is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Gastrointestinal disorders and treatments (3 papers). Thomas Cerny collaborates with scholars based in Switzerland, Germany and United States. Thomas Cerny's co-authors include Giannicola DʼAddario, Frances A. Shepherd, Ronald Feld, Melania Pintilie, Natasha B. Leighl, René Warschkow, Ulrich Güller, Bruno M. Schmied, Ignazio Tarantino and Lukas Marti and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and International Journal of Cancer.

In The Last Decade

Thomas Cerny

28 papers receiving 943 citations

Peers

Thomas Cerny

ONCOL

PRM

SURGE

PFM

Javier Gómez United States

Carlos García Girón Spain

Kazuhiko Yoshimatsu Japan

Takayuki Morita Japan

Hironori Hayashi Japan

Junichi Kaganoi Japan

Jingshan Ho Singapore

Guixiang Liao China

Chiao‐En Wu Taiwan

Elena Ongaro Italy

Javier Gómez United States

Thomas Cerny

361 ×0.7

ONCOL

373 ×0.8

PRM

270 ×1.2

100 ×0.5

SURGE

86 ×0.6

PFM

Citations per year, relative to Thomas Cerny Thomas Cerny (= 1×) peers Javier Gómez

Countries citing papers authored by Thomas Cerny

Since Specialization

Citations

This map shows the geographic impact of Thomas Cerny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Cerny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Cerny more than expected).

Fields of papers citing papers by Thomas Cerny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Cerny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Cerny. The network helps show where Thomas Cerny may publish in the future.

Co-authorship network of co-authors of Thomas Cerny

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Cerny. A scholar is included among the top collaborators of Thomas Cerny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Cerny. Thomas Cerny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mousavi, Seyed Mohsen, Sabine Schmid, Thomas Cerny, & Martin Früh. (2018). Lung cancer and smoking trends in the young in Switzerland: a study based on data of the National Institute for Cancer Epidemiology and Registration and of the Swiss Health Surveys. Swiss Medical Weekly. 148(5152). w14708–w14708. 5 indexed citations

Güller, Ulrich, René Warschkow, Christoph Ackermann, et al.. (2017). Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection. Swiss Medical Weekly. 147(2930). w14473–w14473. 30 indexed citations

Warschkow, René, Michael Christian Sulz, Lukas Marti, et al.. (2016). Better survival in right-sided versus left-sided stage I - III colon cancer patients. BMC Cancer. 16(1). 151 indexed citations

Güller, Ulrich, Ignazio Tarantino, Thomas Cerny, Bruno M. Schmied, & René Warschkow. (2015). Population-based SEER trend analysis of overall and cancer-specific survival in 5138 patients with gastrointestinal stromal tumor. BMC Cancer. 15(1). 557–557. 45 indexed citations

Güller, Ulrich, Ignazio Tarantino, Thomas Cerny, et al.. (2015). Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis. Gastric Cancer. 20(1). 49–60. 27 indexed citations

Tarantino, Ignazio, Ulrich Güller, Alexis Ulrich, et al.. (2013). Relative Survival is an Adequate Estimate of Cancer-Specific Survival: Baseline Mortality-Adjusted 10-Year Survival of 771 Rectal Cancer Patients. Annals of Surgical Oncology. 20(12). 3877–3884. 17 indexed citations

Früh, Martin, et al.. (2011). Extrapulmonary small cell carcinoma: An indication for prophylactic cranial irradiation?. Strahlentherapie und Onkologie. 187(9). 561–567. 14 indexed citations

Bastian, Sara, Thomas Clerici, Jörg Neuweiler, Thomas Cerny, & Martin Früh. (2011). Surgical Resection of Isolated Adrenal Metastases in Patients with Non-Small Cell Lung Cancer: A Single-Institution Experience and Review of the Literature. Onkologie. 34(12). 665–670. 4 indexed citations

Cerny, Thomas, et al.. (2009). Vaccines against nicotine. Human Vaccines. 5(4). 200–205. 44 indexed citations

10.

Joerger, Markus, Samuel Henz, W Zaunbauer, et al.. (2008). CT-Diagnosed Mesenteric Alterations in Patients with Non-Hodgkin’s Lymphoma: A Population-Based Study. Onkologie. 31(10). 4–4. 9 indexed citations

11.

Templeton, Arnoud J., et al.. (2008). Extraneural Spread of Glioblastoma – Report of Two Cases. Onkologie. 31(4). 192–194. 18 indexed citations

12.

Klaeser, Bernd, et al.. (2007). Increased Pulmonary FDG Uptake in Bleomycin-Associated Pneumonitis. Oncology Research and Treatment. 30(6). 320–323. 18 indexed citations

13.

Jermann, Monika, Rolf A. Stahel, Marc Salzberg, et al.. (2005). A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma. Cancer Chemotherapy and Pharmacology. 57(4). 533–539. 44 indexed citations

14.

Calderoni, Antonello & Thomas Cerny. (2001). Taxanes in lung cancer: a review with focus on the European experience. Critical Reviews in Oncology/Hematology. 38(2). 105–127. 15 indexed citations

15.

Betticher, Daniel, et al.. (2000). Pharmacokinetics of 2-chloro-2′-deoxyadenosine administered subcutaneously or by continuous intravenous infusion. Cancer Chemotherapy and Pharmacology. 46(1). 40–42. 9 indexed citations

16.

Cerny, Thomas & Daniel Betticher. (2000). Non-Hodgkin's lymphoma: Role of high-dose therapy in diffuse large B-cell lymphoma. Annals of Oncology. 11. 117–122. 3 indexed citations

17.

Furrer, Markus, Didier Lardinois, Wolfgang Thormann, et al.. (1998). Isolated Lung Perfusion: Single-Pass System Versus Recirculating Blood Perfusion in Pigs. The Annals of Thoracic Surgery. 65(5). 1420–1425. 14 indexed citations

18.

Lohri, Andreas, B van Hille, M. Bacchi, et al.. (1997). Five putative drug resistance parameters (MDR1/P‐glycoprotein, MDR‐associated protein, glutathione‐S‐transferase, bcl‐2 and topoisomerase IIα) in 57 newly diagnosed acute myeloid leukaemias. European Journal Of Haematology. 59(4). 206–215. 27 indexed citations

19.

Lauterburg, Bernhard H., et al.. (1994). Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide/mesna therapy. Cancer Chemotherapy and Pharmacology. 35(2). 132–136. 55 indexed citations

20.

Cerny, Thomas, et al.. (1993). Oral bioavailability of mesna tablets. Cancer Chemotherapy and Pharmacology. 32(1). 78–81. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact